Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
Clinical trial NCT03091777 · COMPLETED
Trial details
- NCT number
- NCT03091777
- Sponsor
- Balmoral Medical company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2017-11-15
- Enrollment
- 871
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.